# Medical Strong Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medical-strong-group

- Industry: Business Support Services
- Headquarters: Beijing, China
- Website: www.medicalstrong.com
- Latest round: Series A (Nov 22, 2019)
- Investors on record: 3

## About

Medical Strong Group is a consulting firm focused on regulatory affairs for the medical device sector, providing services that facilitate product registration and compliance in China.Founded in 2011 by Xiaochen He, Medical Strong Group is headquartered in Beijing, China. The firm specializes in regulatory consulting for medical devices and has successfully completed two deals, with the most recent occurring on November 22, 2019.Medical Strong Group specializes in comprehensive regulatory consulting services for the medical device industry, focusing on the registration, production, and clinical trial research of medical devices, including in vitro diagnostic reagents. Their offerings include regulatory consulting for devices such as dental decay detection software, spinal surgery navigation systems, and single-use microwave ablation catheters, which have successfully received market approval. Serving clients across major Chinese cities like Hangzhou, Wuhan, and Nanjing, the company aids in navigating complex compliance requirements for a diverse clientele.Medical Strong Group generates revenue through a consulting-based business model, engaging clients for regulatory affairs expertise on a project basis. This involves fees for services related to product registrations and compliance guidance, fostering direct B2B interactions with medical device manufacturers and partnerships with healthcare technology firms. Their revenue structure is primarily composed of service fees associated with regulatory submissions and consulting projects.In November 2019, Medical Strong Group raised an undisclosed amount of SERIES A+ funding from Haimaide Venture, which will be utilized to enhance their consulting services and expand their market presence. The company is actively designing new products, particularly in the domain of advanced medical devices, with specific target markets for expansion that include key regions in Southeast Asia by 2024.

## Funding rounds

- Series A, Nov 22, 2019 — HiMed Angle Fund Management
- Series A, Jan 16, 2018 — HighLight Capital, New Vision Ventures

## Investors

- HighLight Capital (https://capitalatlas.ai/funds/highlight-capital) — Series A
- New Vision Ventures (https://capitalatlas.ai/funds/new-vision-ventures) — Series A
- HiMed Angle Fund Management (https://capitalatlas.ai/funds/himed-angle-fund-management) — Series A